Vimta Labs Limited (BOM:524394)

Market Cap	18.97B -0.8%
Revenue (ttm)	3.94B +11.6%
Net Income	741.31M +20.8%
EPS	16.49 +20.8%
Shares Out	44.64M
PE Ratio	25.58
Forward PE	n/a
Dividend	1.00 (0.24%)
Ex-Dividend Date	May 30, 2025

Volume	16,282
Average Volume	14,924
Open	455.90
Previous Close	448.25
Day's Range	427.80 - 455.90
52-Week Range	372.50 - 902.85
Beta	-0.56
RSI	28.82
Earnings Date	Jan 28, 2026

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu...

• Industry: Commercial Physical and Biological Research
• Founded: 1984
• Employees: 1,315
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524394

Financial Performance

In fiscal year 2025, Vimta Labs's revenue was 3.45 billion, an increase of 19.25% compared to the previous year's 2.90 billion. Earnings were 667.55 million, an increase of 36.76%.